Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 5, 2014, Pages

  Jacobs, Robert L ^a   Harper, Nathan ^b,c   He, Weijing ^b,c   Andrews, Charles P ^a   Rather, Cynthia G ^a   Ramirez, Daniel A ^a   Ahuja, Sunil K ^b,c  

^a Biogenics Research Chamber LLC   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Allergy; challenge; confounding; pollen; season

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOPHENOTYPE; EOSINOPHIL COUNT; FEMALE; HAY FEVER; HUMAN; MALE; POLLEN; POLLINATION; PRIORITY JOURNAL; RAGWEED; RAGWEED POLLEN; SYMPTOM; ADULT; AGED; COMPARATIVE STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; NONHUMAN; OAK; SYMPTOMATOLOGY; UNITED STATES;

ALLERGY; CHALLENGE; CONFOUNDING; POLLEN; SEASON;

ADOLESCENT; ADULT; AGED; AMBROSIA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POLLEN; QUERCUS; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TIME FACTORS;

EID: 84899618678     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.09.051     Document Type: Article

References (23)

1. M.S. Blaiss Allergic rhinoconjunctivitis: burden of disease Allergy Asthma Proc 28 2007 393 397
2. M.S. Blaiss Quality of life in allergic rhinitis Ann Allergy Asthma Immunology 83 1999 449 454
3. N. Bhattacharyya Incremental healthcare utilization and expenditures for allergic rhinitis in the United States Laryngoscope 121 2011 1830 1833
4. A. Akerlund, M. Andersson, J. Leflein, T. Lildholdt, and N. Mygind Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication J Allergy Clin Immunol 115 Suppl 2005 S460 S482
5. S.Y. Lin, N. Erekosima, J.M. Kim, M. Ramanathan, C. Suarez-Cuervo, Y. Chelladurai, and D. Ward et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review JAMA 309 2013 1278 1288
6. R.B. Berkowitz, G.G. Woodworth, C. Lutz, K. Weiler, J. Weiler, and M. Moss et al. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit Ann Allergy Asthma Immunology 89 2002 38 45
7. J.H. Day, and M.P. Briscoe Environmental exposure unit: a system to test anti-allergic treatment Ann Allergy Asthma Immunology 83 1999 83 93
8. K. Hashiguchi, H. Tang, T. Fujita, K. Suematsu, S. Tsubaki, and S. Kitajima et al. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis Int Arch Allergy Immunol 149 2009 141 149
9. S.M. Ronborg, H. Mosbech, C.R. Johnsen, and L.K. Poulsen Exposure chamber for allergen challenge. The development and validation of a new concept Allergy 51 1996 82 88
10. P. Badorrek, M. Dick, H. Hecker, F. Schaumann, A.R. Sousa, and R. Murdoch et al. Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season Ann Allergy Asthma Immunol 106 2011 336 341
11. J.M. Hohlfeld, T. Holland-Letz, M. Larbig, M. Lavae-Mokhtari, E. Wierenga, and M. Kapsenberg et al. Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions Clin Exp Allergy 40 2010 998 1006
12. J.A. Bernstein Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: early evidence supporting a paradigm shift in drug investigation? J Allergy Clin Immunol 130 2012 128 129
13. R.L. Jacobs, N. Harper, W. He, C.P. Andrews, C.G. Rather, and D.A. Ramirez et al. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes J Allergy Clin Immunol 130 2012 122 127.e128
14. T.F. Carr, and C.A. Saltoun Chapter 2: skin testing in allergy Allergy Asthma Proc 33 Suppl 1 2012 S6 S8
15. R.L. Jacobs, D.A. Ramirez, and C.P. Andrews Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen Ann Allergy Asthma Immunology 107 2011 133 138
16. J.H. Everitt, R.L. Lonard, and C.R. Little Weeds in South Texas and northern Mexico 2007 Texas Tech University Press Lubbock (TX)
17. N.F. Adkinson, B.S. Bochner, A.W. Burks, W.W. Busse, S.T. Holgate, and R.F. Lemanske et al. Allergic and non-allergic rhinitis Middleton's allergy seventh edition, principles & practice 2009 Elsevier Amsterdam 973 987
18. B.J. Simpson A field guide to Texas trees 1999 Gulf Publishing Houston
19. L.S. Cox, T.B. Casale, A.S. Nayak, D.I. Bernstein, P.S. Creticos, and L. Ambroisine et al. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE J Allergy Clin Immunol 130 2012 1327 1334.e1321
20. A.K. Ellis, J.D. Ratz, A.G. Day, and J.H. Day Factors that affect the allergic rhinitis response to ragweed allergen exposure Ann Allergy Asthma Immunology 104 2010 293 298
21. R.L. Jacobs, D.A. Ramirez, and C.P. Andrews Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen Ann Allergy Asthma Immunol 107 2011 133 138
22. A.K. Ellis, J.D. Ratz, A.G. Day, and J.H. Day Factors that affect the allergic rhinitis response to ragweed allergen exposure Ann Allergy Asthma Immunol 104 2010 293 298
23. R.L. Jacobs, N. Harper, W. He, C.P. Andrews, C.G. Rather, and D.A. Ramirez et al. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes J Allergy Clin Immunol 130 2012 122 127.e128